RxDoctor Payments Data

Shane Rothermel, MD

Adult Reconstructive Orthopaedic Surgery · Pueblo, CONPI 1083000541

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (55.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 89.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $6,770 and has fallen 61.1% since, to $2,636 in 2025.

$18,250in general payments, 2019–2025

Across 69 payments — averaging $264.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$16K
  • Stryker$649
  • Ortho Development Corporation$595
  • Johnson & Johnson$568
  • Medacta USA, Inc.$37
  • Avanos Medical$36
  • plus $67 from 3 others

What the payments were for

  • Travel & lodging$4,65425%
  • Food & beverage$3,49619%
  • Education$10,10055%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,250 in reported general payments places this provider in the 60th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.

See all adult reconstructive orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$228,958
Medicare patients
327
Services billed
1,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib55$989
Amoxicillin60$96

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →